NEW YORK (Reuters Health) – Women with latent celiac disease — positive celiac antibodies but a normal small bowel biopsy — may be at increased risk of reproductive…
NEW YORK (Reuters Health) – HCV genotype 4, previously limited to Egypt and parts of Africa, has now spread to southern Europe and other parts of world, an…
NEW YORK (Reuters Health) – By restoring cognitive function in patients with minimal hepatic encephalopathy (MHE), rifaximin treatment also improves their quality of life, investigators in India report.…
NEW YORK (Reuters Health) – Having an on-site pathologist interpret tissue samples at endoscopic retrograde cholangiopancreatography (ERCP) can lead to immediate diagnosis, researchers report in the November 23rd…
NEW YORK (Reuters Health) – Band ligation of bleeding esophageal varices can be impossible when blood obscures the endoscopic view – but giving erythromycin before the procedure will…
NEW YORK (Reuters Health) – Urologists from China report that the alpha-adrenergic receptor antagonist tamsulosin is a good first-line drug for outpatient medical expulsive therapy (MET) in patients…
NEW YORK (Reuters Health) – Anemia that develops in hepatitis C virus (HCV) patients during treatment with peginterferon-alfa and ribavirin (PEG-IFN/RBV) may be a good sign, new research…
NEW YORK (Reuters Health) – A molecular complex of aspirin and phosphatidylcholine called PL2200 seems to protect against acute gastroduodenal erosion and ulceration in older adults at risk…
NEW YORK (Reuters Health) – In adolescents and adults with active eosinophilic esophagitis (EoE), a 15-day induction course of nebulized budesonide is sufficient to induce histologic remission and…
NEW YORK (Reuters Health) – An “evolving concept” in the treatment of inflammatory bowel disease is to use biologic agents to obviate long-term treatment with steroids, according to…